Androgen receptor pathway inhibitors (ARPIs) in combination with androgen deprivation therapy (ADT) represent the foundation ...

Bayer AG (($BAYRY)) announced an update on their ongoing clinical study. Bayer AG is conducting a Phase 1 clinical study titled A Phase 1 ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 2 Open-label Extension ...

Fresh from a European cancer conference that was all about antibody-drug conjugates (ADCs), GSK has turned to French biotech ...

Enlarged prostate is a common non-cancerous condition that affects older men but many patients wait months for care.

Prostate cancer is the second most common cancer diagnosis in men. 1 in 8 men will be diagnosed with the disease during their ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.

The UK’s approach to prostate cancer is failing men from pre-diagnosis through to advanced disease management, according to new reports. Experts cite three critical failings: the lack of a screening ...

WASHINGTON (AP) — Former President Joe Biden is receiving radiation and hormone therapy as part of a new phase of treating the aggressive form of prostate cancer he was diagnosed with after leaving ...

WASHINGTON — Former President Joe Biden is receiving radiation and hormone therapy as part of a new phase of treating the aggressive form of prostate cancer he was diagnosed with after leaving office, ...